Priority Date: 13.09.06 (DE 20061042927)

TARTRATE DERIVATIVES FOR USE AS COAGULATION FACTOR IXa INHIBITORS

  • Application ID: EP07802030
  • Status: No opposition filed within time limit

Applicants

Technology company logo small
Technology Company
Technology company logo small
Technology Company

Attorney

no operation time available
1 office
Technology Company

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C07 (ORGANIC CHEMISTRY). Sanofi-Aventis Deutschland GmbH is specialized in the combination A61 and C07. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 221 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 13.09.2006 - Priority Date (DE 20061042927)
  • 20.03.2008 - Publication A1 (WO2008031508)
  • 17.06.2009 - Publication A1 (EP2069288)
  • 26.03.2014 - Publication B1 (EP2069288)